Arlington Trust’s Ambev ABEV Stock Holding History

Arlington Trust’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,164	Closed	-$3.26K	–	495
2023 Q4	$3.26K	Buy	+1,164	New	+$3.14K	﹤0.01%	534

Other funds holding ABEV

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

WGI

Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SIM

Sprucegrove Investment Management Toronto, Ontario, Canada $639M AUM 23.31% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arlington Trust's ABEV Position: Q1 2024 in Review

Arlington Trust sold out of Ambev (ABEV) in Q1 2024, closing a stake of 1,164 shares — an estimated $3.26K sold.

Arlington Trust first reported a position in ABEV in Q4 2023 and held it in 1 quarter. The position peaked at $3.26K in Q4 2023. 349 funds tracked by Wall St. Rank hold ABEV as of Q1 2024.

Arlington Trust reported no remaining Ambev position as of Q1 2024 after selling out during the quarter.
Arlington Trust sold 1,164 Ambev shares in Q1 2024, an estimated $3.26K.
Arlington Trust first reported a position in Ambev in Q4 2023 and held it in 1 quarter.
Arlington Trust's Ambev position peaked at $3.26K in Q4 2023.
349 funds tracked by Wall St. Rank held Ambev as of Q1 2024.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.